Fund Holdings — Patient Square Capital LP

Total Portfolio Value:
$373.86M
Total Bought:
$54.26M
Total Sold:
$37.49M
Net Transaction:
+$16.76M
Securities
▲▼
SharesValue
Q2 2025
▲▼
Q3 2025
▲▼
Change
▲▼
Q2 2025
▲▼
Q3 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Roivant Sciences Ltd.SHS(ROIV)12,480,00012,480,0000$140.65M$188.82M50.51%+$48.17M
Insmed Incorporated(INSM)358,800326,400-32,400$36.11M$47.00M12.57%+$10.90M
EyePoint, Inc.(EYPT)1,352,8371,011,839-340,998$12.73M$14.41M3.85%+$1.68M
ABIVAX Société AnonymeADS(ABVX)0151,833+151,833$0$12.89M3.45%+$12.89M
Cidara Therapeutics Inc15,000121,000+106,000$730.6K$11.59M3.10%+$10.86M
argenx SEADR(ARGX)29,00015,500-13,500$15.99M$11.43M3.06%-$4.55M
Liquidia Corporation(LQDA)1,020,000400,000-620,000$12.71M$9.10M2.43%-$3.61M
Pharvaris N V
COM
244,283345,381+101,098$4.30M$8.62M2.30%+$4.32M
Ocular Therapeutix, Inc.(OCUL)817,699715,000-102,699$7.59M$8.36M2.24%+$770.1K
Mirum Pharmaceuticals, Inc.(MIRM)113,462104,262-9,200$5.77M$7.64M2.04%+$1.87M
Agios Pharmaceuticals, Inc.(AGIO)139,732133,827-5,905$4.65M$5.37M1.44%+$724.3K
Kymera Therapeutics, Inc.(KYMR)140,00092,592-47,408$6.11M$5.24M1.40%-$868.9K
Enliven Therapeutics Inc245,838250,838+5,000$4.93M$5.13M1.37%+$203.1K
Celcuity Inc.(CELC)0100,000+100,000$0$4.94M1.32%+$4.94M
Dianthus Therapeutics, Inc.(DNTH)0125,000+125,000$0$4.92M1.32%+$4.92M
Disc Medicine, Inc.(IRON)74,00074,0000$3.92M$4.89M1.31%+$970.9K
uniQure N.V.SHS(QURE)075,000+75,000$0$4.38M1.17%+$4.38M
Amylyx Pharmaceuticals, Inc.(AMLX)0316,312+316,312$0$4.30M1.15%+$4.30M
Nurix Therapeutics, Inc.(NRIX)412,296437,237+24,941$4.70M$4.04M1.08%-$656.0K
Allogene Therapeutics Inc2,635,0002,981,396+346,396$2.98M$3.70M0.99%+$719.4K
Assembly Biosciences Inc0135,182+135,182$0$3.46M0.93%+$3.46M
Avalo Therapeutics, Inc.(AVTX)0100,000+100,000$0$1.27M0.34%+$1.27M
Perspective Therapeutics, Inc.(CATX)0349,323+349,323$0$1.20M0.32%+$1.20M
Geron Corporation(GERN)716,000845,000+129,000$1.01M$1.16M0.31%+$148.1K
Cullinan Therapeutics, Inc.(CGEM)868,8970-868,897$6.54M$0—-$6.54M
Scholar Rock Holding Corporation(SRRK)154,0000-154,000$5.45M$0—-$5.45M
Yarrow Bioscience Inc(YARW)317,0330-317,033$523.1K$0—-$523.1K
Page 1 of 1
Patient Square Capital LP — 13F Holdings — Q3 2025 | TickerTrail